Stoke Therapeutics Inc (STOK)

EBITDA Margin

-751.40%

TTM · Period ending:

STOK logo

STOK EBITDA Margin

Latest reported-751.40%
STOK TTM EBITDA Margin (-3089.20% → -751.40%)
High-resolution chart · PNG

STOK ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Stoke Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-751.4028%
-515.4707%
-2.4737%
20.915%
27.8903%
28.0978%
-237.4614%
-616.2695%
-667.6585%
-1,352.3646%
-1,164.2182%
-1,091.5009%
-1,161.7863%
-666.8063%
-802.2652%
-1,080.2102%
-1,529.5779%
-3,089.2%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.